Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis | Zendy

Ulrich Specks | Zendy; Peter A. Merkel | Zendy; Philip Seo | Zendy; Robert Spiera | Zendy; Carol A. Langford | Zendy; Gary S. Hoffman | Zendy; Cees G. M. Kallenberg | Zendy; E. William St. Clair | Zendy; Barri J. Fessler | Zendy; Linna Ding | Zendy; Lisa Viviano | Zendy; Nadia K. Tchao | Zendy; Deborah Phippard | Zendy; Adam L. Asare | Zendy; Noha Lim | Zendy; David Iklé | Zendy; Brett Jepson | Zendy; Paul Brunetta | Zendy; Nancy B. Allen | Zendy; Fernando C. Fervenza | Zendy; Duvuru Geetha | Zendy; Karina A. Keogh | Zendy; Eugene Y. Kissin | Zendy; Paul A. Monach | Zendy; Tobias Peikert | Zendy; Coen A. Stegeman | Zendy; Steven R. Ytterberg | Zendy; Mark Mueller | Zendy; Lourdes P. Sejismundo | Zendy; Kathleen Mieras | Zendy; John H. Stone | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis

Author(s) -

Ulrich Specks,

Peter A. Merkel,

Philip Seo,

Robert Spiera,

Carol A. Langford,

Gary S. Hoffman,

Cees G. M. Kallenberg,

E. William St. Clair,

Barri J. Fessler,

Linna Ding,

Lisa Viviano,

Nadia K. Tchao,

Deborah Phippard,

Adam L. Asare,

Noha Lim,

David Iklé,

Brett Jepson,

Paul Brunetta,

Nancy B. Allen,

Fernando C. Fervenza,

Duvuru Geetha,

Karina A. Keogh,

Eugene Y. Kissin,

Paul A. Monach,

Tobias Peikert,

Coen A. Stegeman,

Steven R. Ytterberg,

Mark Mueller,

Lourdes P. Sejismundo,

Kathleen Mieras,

John H. Stone

Publication year - 2013

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1213277

Subject(s) - azathioprine , rituximab , immunosuppression , medicine , cyclophosphamide , vasculitis , anti neutrophil cytoplasmic antibody , anca associated vasculitis , immunology , gastroenterology , antibody , chemotherapy , disease

The 18-month efficacy of a single course of rituximab as compared with conventional immunosuppression with cyclophosphamide followed by azathioprine in patients with severe (organ-threatening) antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis is unknown.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research